I fully agree.......all OTC companies face the same issue of initial financing........its called gambling........... most dont make it....
IF one noticed this director's past history......that in itself is a reason to buy this stock IMHO
"Upper management in two premier startup Biotech Oraganizations. Genentech, 1986 - 1995, then snatched up to start up MedImmune :"Endorsers who were Kim’s colleagues at Genentech"